Shenzhen Salubris Pharmaceuticals Co., Ltd. (SHE:002294)
China flag China · Delayed Price · Currency is CNY
46.18
+0.55 (1.21%)
Feb 3, 2026, 3:04 PM CST

SHE:002294 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
992.221,1251,3222,6703,236865.13
Short-Term Investments
883.91988.85695.51531.58--
Trading Asset Securities
545.66733.86186.06328.3660214.59
Cash & Short-Term Investments
2,4222,8482,2043,5303,2961,080
Cash Growth
26.81%29.25%-37.58%7.12%205.25%-18.20%
Accounts Receivable
791.23565.87545.38557.72474.03526.57
Other Receivables
28.2923.8521.0123.4155.4830.63
Receivables
819.51589.72566.39581.12629.51557.2
Inventory
523.25506.76490.86543.53420.45391.56
Prepaid Expenses
-----1.13
Other Current Assets
602.1480.0252.4356.3658102.31
Total Current Assets
4,3674,0253,3134,7114,4042,132
Property, Plant & Equipment
1,4801,4301,4571,5061,6381,507
Long-Term Investments
887.811,8401,701963.07854.48835.67
Goodwill
219.4910.9110.9160.5387.1487.14
Other Intangible Assets
1,4771,3351,318965.461,0481,244
Long-Term Deferred Tax Assets
132.9151.2487.488.4282.0198.26
Long-Term Deferred Charges
1,9641,5971,4161,3441,047816.84
Other Long-Term Assets
456.5677.2693.31116.6483.09197.43
Total Assets
10,98410,4669,3979,7559,2446,918
Accounts Payable
158.21126.09156.01219.65187.67223.39
Accrued Expenses
229.06717.67491.34558.35487.02327.04
Short-Term Debt
214.2812040177.1963300.26
Current Portion of Leases
12.049.710.9311.466.99-
Current Income Taxes Payable
84.737.1510.4928.9237.210.7
Current Unearned Revenue
40.1538.3629.5542.6697.9953.23
Other Current Liabilities
646.169476.77565.4132.98182.37
Total Current Liabilities
1,3851,113815.081,6041,0131,097
Long-Term Debt
-----90
Long-Term Leases
17.034.1812.5419.589.11-
Long-Term Unearned Revenue
115.49142.0484.1198.5393.7189.61
Long-Term Deferred Tax Liabilities
33.2620.9713.0427.18-19.82
Other Long-Term Liabilities
502.04433.14416.4729.6482.5730.41
Total Liabilities
2,0521,7131,3411,7791,1981,327
Common Stock
1,1151,1151,1151,1151,1151,046
Additional Paid-In Capital
1,9721,9281,9001,8661,930-
Retained Earnings
5,6465,6205,5645,5295,3304,798
Treasury Stock
---602.16-602.16-327.86-327.75
Comprehensive Income & Other
39.7649.342.2233.24-13.41-7.69
Total Common Equity
8,7738,7128,0197,9418,0345,508
Minority Interest
159.0140.1736.4335.8111.9183.33
Shareholders' Equity
8,9328,7528,0557,9778,0465,592
Total Liabilities & Equity
10,98410,4669,3979,7559,2446,918
Total Debt
243.35133.8863.47208.2379.1390.26
Net Cash (Debt)
2,1782,7142,1403,3223,217689.46
Net Cash Growth
18.95%26.83%-35.58%3.28%366.56%-29.40%
Net Cash Per Share
1.942.441.923.023.010.68
Filing Date Shares Outstanding
1,1151,1151,0911,0911,1031,029
Total Common Shares Outstanding
1,1151,1151,0911,0911,1031,029
Working Capital
2,9822,9122,4983,1083,3911,035
Book Value Per Share
7.877.817.357.287.295.36
Tangible Book Value
7,0767,3666,6906,9156,8984,177
Tangible Book Value Per Share
6.356.616.136.346.264.06
Buildings
-1,2221,2181,2081,218946.22
Machinery
-1,2581,2031,1381,109923.7
Construction In Progress
-62.3334.3537.694.13343.78
Source: S&P Global Market Intelligence. Standard template. Financial Sources.